| Trial ID: | L1062 |
| Source ID: | NCT02944214
|
| Associated Drug: |
Febuxostat
|
| Title: |
Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Hyperuricemia|Abnormal Renal Function
|
| Interventions: |
DRUG: Febuxostat|DRUG: Benzbromarone
|
| Outcome Measures: |
Primary: serum creatinine, estimated glomerular filtration rate (eGFR), eGFR will be estimated by CKD-EPI equation, which is most widely used recently in the world. eGFR will be calculated according to serum creatinine, age, gender and race., up to 12th months | Secondary: urine protein, 6th months, 12th months|adverse drug reaction, 1st month, 2nd months, 3rd months, 6th months, 9th months, 12th months
|
| Sponsor/Collaborators: |
Sponsor: Shanghai 10th People's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
800
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-10
|
| Completion Date: |
2019-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-25
|
| Locations: |
Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai, Shanghai, 200072, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02944214
|
